Acute Inflammatory Pain
The CFA-induced and Carrageenan-induced inflammatory pain models.
Pain associated with tissue injury
Acute Inflammatory pain is commonly associated with tissue injury and manifests itself as an expression of neuronal plasticity consisting of central and peripheral sensitization. Tissue injury causes a release of inflammatory mediators from damaged cells, which become central to the initiation of an inflammatory cascade.
MD Biosciences offers acute inflammatory pain models that can be extended to evaluate a more chronic inflammatory pain state. In models like CFA or carrageenan, we can measure the release of cytokines and their role in the initiation and maintenance of the inflammatory response.
Acute inflammatory pain models:
-
CFA-Induced Inflammatory Pain
Available in both mouse and rat models, the CFA-induced inflammatory pain model exhibits peripheral tissue injury following an injection of complete freund's adjuvant (CFA).
-
Carrageenan-Induced Inflammatory Pain
Available in both mouse and rat models, the carrageenan-induced inflammatory pain model induces a short-lasting acute inflammation and hyperalgesia.
Scientific Data
Biomarkers are used to analyze pro-inflammatory and anti-inflammatory cytokines in paw skin, CSF, and plasma. Analysis of these sample types provide information on local and systemic effects of a drug.
CFA Inflammatory Pain Datasheet
Complete the short form for instant access to the complete data set.
Assessments
Inflammatory biomarkers provide information related to mechanisms contributing to inflammatory pain and how well compounds modulate the inflammatory and/or pain response.
Behavior
Pain behavior tests include dynamic weightbearing and Hargreaves to assess the distribution on each paw and sensitivity to heat.
Biomarkers
Evaluate pro-inflammatory and anti-inflammatory biomarkers from samples.
Histology
IHC and histological staining to evaluate inflammatory markers in the paw skin.
READY TO DISCUSS YOUR PROGRAM?
At MD Biosciences, we’re not just a service provider—we’re your dedicated partner in drug development. With industry-leading expertise, we offer tailored study designs, translational models, and comprehensive endpoint assessments. Our commitment to short lead times and competitive pricing, combined with our deep scientific knowledge, ensures your research progresses efficiently and effectively. Collaborate with us to turn your scientific vision into reality.